| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/09/2002 | US6416946 Contacting sample with composition comprising reagent consisting essentially of combination of hepatitis c type specific epitopes under conditions which allow formation of epitope-antibody complexes, assaying for presence of complexes |
| 07/09/2002 | US6416945 Disassembling virus-like particles of l1 proteins or mixture of l1 and l2 proteins by contacting for prolonged time period with concentrated reducing agent solution, adding moiety to be encapsulated, reassembling by removing reducing agent |
| 07/09/2002 | US6416944 Methods of typing hepatitis C virus and reagents for use therein |
| 07/09/2002 | US6416763 Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| 07/09/2002 | US6416761 Rio Mamoré hantavirus nucleocapsid protein and diagnostic methods employing said protein |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | US6416734 Recombinant alpha-fetoprotein for treating and diagnosing cancers |
| 07/09/2002 | CA2221793C Novel antibacterial protein |
| 07/09/2002 | CA2133845C Adrenocorticotrophic hormone receptor and uses |
| 07/09/2002 | CA2096495C Dual analyte immunoassay |
| 07/09/2002 | CA2077434C Antigenic proteins of borrelia burgdorferi |
| 07/09/2002 | CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 |
| 07/04/2002 | WO2002052342A1 Silver-dispersing polypeptides |
| 07/04/2002 | WO2002052276A2 Protein s functional assay |
| 07/04/2002 | WO2002052274A2 Screening method based on tsap6 binding partners |
| 07/04/2002 | WO2002052273A1 Screening method based on siah-numb interaction |
| 07/04/2002 | WO2002052270A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | WO2002052047A2 Methods for identifying g-protein coupled receptors associated with diseases |
| 07/04/2002 | WO2002052046A2 Oligonucleotide transfection screening method |
| 07/04/2002 | WO2002052030A2 Compositions and methods enabling a totally internally controlled amplification reaction |
| 07/04/2002 | WO2002052023A2 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 07/04/2002 | WO2002052022A2 Selective cytotoxic fusion proteins |
| 07/04/2002 | WO2002052015A2 Self-replicating rna molecule from hepatitis c virus |
| 07/04/2002 | WO2002052014A2 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
| 07/04/2002 | WO2002052013A2 The flu gene: a tool for the identification of genes involved in stress responses and apoptosis and a target for herbicides specific for angiosperms |
| 07/04/2002 | WO2002052012A2 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | WO2002052011A2 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
| 07/04/2002 | WO2002052010A1 Estrogen receptor genes and utilization thereof |
| 07/04/2002 | WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 07/04/2002 | WO2002052008A1 Novel cancer-associated genes |
| 07/04/2002 | WO2002052007A1 Synovial membrane cell protein |
| 07/04/2002 | WO2002052005A1 Novel genes and proteins encoded thereby |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052003A2 Regulation of human calcium channel |
| 07/04/2002 | WO2002052000A1 Novel potassium channel |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051990A2 Proteases of endogenous retroviruses, substrates thereof and method for screening inhibitors |
| 07/04/2002 | WO2002051981A2 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | WO2002051979A2 Method to remove citrate and aluminum from proteins |
| 07/04/2002 | WO2002051978A2 Yeasts transformed by genes enhancing their cold stress tolerance |
| 07/04/2002 | WO2002051977A2 orfE-ZipA INTERACTION AND USES THEREOF |
| 07/04/2002 | WO2002051869A1 Compounds comprising two or more identical protein domains interlinked by a peptide having such a length that each of the protein domains can interact simultaneously with its specific cell-surface structure and thereby block the function of the structure |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051867A1 A novel polypeptide-corticotropin releasing factor 8.8 and the polynucleotide encoding said polypeptide |
| 07/04/2002 | WO2002051866A2 Antibacterial treatments |
| 07/04/2002 | WO2002051865A2 Proteinic antigens inducing antibodies neutralising hiv virus |
| 07/04/2002 | WO2002051864A1 Protein cluster ii |
| 07/04/2002 | WO2002051863A2 Polypeptides having a triggering nk activity and biological applications |
| 07/04/2002 | WO2002051860A2 Synthetic peptide composition as immunogens for prevention of urinary tract infection |
| 07/04/2002 | WO2002051859A2 Haplotypes of the ptafr gene |
| 07/04/2002 | WO2002051794A2 Connectable biochemical pincers and synthetic receptors for molecular organisation and manipulation of biomolecules |
| 07/04/2002 | WO2002051439A2 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051433A2 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002051233A2 Universal antimicrobial treatment |
| 07/04/2002 | WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/04/2002 | WO2002030263A3 Transmission assembly for a surgical biopsy device |
| 07/04/2002 | WO2002029023A8 Nicastrin protein |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002023202A8 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 07/04/2002 | WO2002020609A3 Interleukin-11 for the treatment of stroke and neuropathies |
| 07/04/2002 | WO2002018430A3 Nucleotide sequences which code for the metr and metz genes |
| 07/04/2002 | WO2002014473A8 Animals expressing exogenous igf-i in their milk |
| 07/04/2002 | WO2002014363A3 Influencing the distribution of metals in transgenic plants |
| 07/04/2002 | WO2002012439A8 Genes associated with renal disease |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2002000700A3 Regulation of human p2y8-like g protein-coupled receptor |
| 07/04/2002 | WO2001096373A3 Fluorescent timer proteins and methods for their use |
| 07/04/2002 | WO2001094588A3 Gene (cur) related to a curly phenotype in plants |
| 07/04/2002 | WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001085793A3 G protein-coupled receptors |
| 07/04/2002 | WO2001081414A3 Integrin alpha subunit and uses thereof |
| 07/04/2002 | WO2001079481A3 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | WO2001077175A3 G protein-coupled receptors |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001064886A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/04/2002 | WO2001059089A3 Improved galactosylation of recombinant glycoproteins |
| 07/04/2002 | WO2001057207A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001053456A8 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001046420A8 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 07/04/2002 | WO2001042470A9 Nucleic acid and protein expressed thereby and their involvement in stress |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |